PDF Publication Title:
Text from PDF Page: 012
Healthcare 2020, 8, 10 12 of 14 Healthcare 2020, 8, x FOR PEER REVIEW 12 of 14 Figure A2. Individual patient-level plots of depressive symptoms over the course of each Figure A2. Individual patient-level plots of depressive symptoms over the course of each personalized 1.. 2.. 3.. Miittcchelll,,A.J.;;CChhaann,,MM.;B.;hBathtai,ttHi,.;H.a;ltHona,ltMon.;,GMra.;ssGi,rLa.s;sJio,hLan.;seJonh,Can.;sMene,adCe.;r,MN.ePadrevra,leNn.cePorefvdaelpernecsesionf, daenpxriestys,ioan,daandxjuiesttym,eantddaisdojurdsetmriennotndcioslorgdiecarli,nhaoenmcoaltogloicgaicl,ahl,aenmdaptaolloiagtiicvael-,canredspetatlilniagtsi:vAe-cmaeretas-aenttainlygsi:s Aofm94etian-taenravliyeswis-boafs9e4disnttuedrvieies.wL-abnacsetdOsntucodli.e2s0.1L1a,n1c2et,1O6n0c–o1l.7240.1[C1,r1o2ss,R16e0f]–174. Liindeenn,,W..;;Vodermaiierr,, A..;; Mackenziiee,,R..;;Grreeigig,,D..Anxxieiettyyaanddeeprreesssioionnaafftteerrccaanncceerrdiaiaggnnoossisis:: Prreevallencerrattesbycancertype,,gender,andage.J.Affffect.Diisord..2012,,141,,343–351.. [CrossRef][PubMed] Piirrl,l,W..F.. Evidencereporttontheoccurrence,,asssesssmeentt,,aandttrreeaattmeennttooffdeepprreesssioionnininccaanncceerrppaatiteienntsts.. JNCI Monogr. 2004, 32, 32–39. [CrossRef] [PubMed] JNCI Monogr. 2004, 32, 32–39. Arrieta, Ó.; Angulo, L.P.; Núñez-Valencia, C.; Dorantes-Gallareta, Y.; Macedo, E.O.; Martínez-López, D.; Arrieta, Ó.; Angulo, L.P.; Núñez-Valencia, C.; Dorantes-Gallareta, Y.; Macedo, E.O.; Martínez-López, D.; 4. 4. 5. Mausbach, B.T.; Schwab, R.B.; Irwin, S.A. Depression as a predictor of adherence to adjuvant endocrine 5. Mausbach, B.T.; Schwab, R.B.; Irwin, S.A. Depression as a predictor of adherence to adjuvant endocrine 6. DiMatteo, M.R.; Lepper, H.S.; Croghan, T.W. Depression is a risk factor for noncompliance with medical 6. DiMatteo, M.R.; Lepper, H.S.; Croghan, T.W. Depression is a risk factor for noncompliance with medical 7. treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000, 160, 2101–2107. [CrossRef] 2000, 160, 2101–2107. Pinquart, M.; Duberstein, P.R. Depression and cancer mortality: A meta-analysis. Psychol. Med. 2010, 40, Pinquart, M.; Duberstein, P.R. Depression and cancer mortality: A meta-analysis. Psychol. Med. 2010, 40, 1797–1810. [CrossRef] 1797–1810. 7. 8. Satin, J.R.; Linden, W.; Phillips, M.J. Depression as a predictor of disease progression and mortality in cancer 8. Satin, J.R.; Linden, W.; Phillips, M.J. Depression as a predictor of disease progression and mortality in 9. Pan, X.; Sambamoorthi, U. Health care expenditures associated with depression in adults with cancer. 9. Pan, X.; Sambamoorthi, U. Health care expenditures associated with depression in adults with cancer. J. J. Community Support Oncol. 2015, 13, 240–247. [CrossRef] 10. Community Support Oncol. 2015, 13, 240–247. Richardson, M.A.; Sanders, T.; Palmer, J.L.; Greisinger, A.; Singletary, S.E. Complementary/alternative 10. Richardson, M.A.; Sanders, T.; Palmer, J.L.; Greisinger, A.; Singletary, S.E. Complementary/alternative 11. Owen, D.K.; Lewith, G.; Stephens, C.R. Can doctors respond to patients’ increasing interest in complementary 11. 12. Owen, D.K.; Lewith, G.; Stephens, C.R. Can doctors respond to patients’ increasing interest in personalized trial for eight patients who completed the 12-week protocol. Black dots refer to bright trial for eight patients who completed the 12-week protocol. Black dots refer to bright white light therapy wtrheiattemliegnhttptheeriroadpsy, tarnedatmreedndt optesriroedfesr, atondirmedrdedotsligrehfterthteordapimy rtreedatlimghent thpeerraipoydst.reSaytmepnttompesriwodesr.e Sryempoprtoedmastwtheerenrdepoofrtheeddaatythuesinengda 0of(nthoeddeparyesussiivnegsyam0p(tnoomds)etpore1s0s(ivsevseyremdpetpormess)ivtoe s1y0m(spetvoemres) dveispureasl sainvaelosygmscpatloem. s) visual analog scale. Refferrences Alvarado, S.; Corona-Cruz, J.F.; Oñate-Ocaña, L.F. Association of depression and anxiety on quality of life, Alvarado, S.; Corona-Cruz, J.F.; Oñate-Ocaña, L.F. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann. Surg. Oncol. treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann. Surg. Oncol. 2013, 20, 1941–1948. [CrossRef] [PubMed] 2013, 20, 1941–1948. therapy (AET) in women with breast cancer: A systematic review and meta-analysis. Breast Cancer Res. Treat. therapy (AET) in women with breast cancer: A systematic review and meta-analysis. Breast Cancer Res. 2015, 152, 239–246. [CrossRef] [PubMed] Treat. 2015, 152, 239–246. patients: A meta-analysis. Cancer 2009, 115, 5349–5361. [CrossRef] cancer patients: A meta-analysis. Cancer 2009, 115, 5349–5361. medicine use in a comprehensive cancer center and the implications for oncology. J. Clin. Oncol. 2000, 18, medicine use in a comprehensive cancer center and the implications for oncology. J. Clin. Oncol. 2000, 18, 2505–2514. [CrossRef] 2505–2514. and alternative medicine? BMJ 2001, 322, 154–158. [CrossRef] complementary and alternative medicine? BMJ 2001, 322, 154–158. Mao, J.J.; Palmer, C.S.; Healy, K.E.; Desai, K.; Amsterdam, J. Complementary and alternative medicine use among cancer survivors: A population-based study. J. Cancer Surviv. 2011, 5, 8–17.PDF Image | Bright White Light Therapy for Depression in Cancer Survivors
PDF Search Title:
Bright White Light Therapy for Depression in Cancer SurvivorsOriginal File Name Searched:
healthcare-08-00010.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com (Standard Web Page)